Publication Date




Download Full Text (503 KB)


Nontuberculous mycobacterial (NTM) disease is a challenge to manage in patients with cystic fibrosis (CF). Diagnosis of NTM pulmonary disease is complex. Effective treatment requires long term, multi-drug therapy delivered by several routes. Consensus recommendations published in 2016 were developed to guide CF providers in NTM screening, diagnosis and management. Primary Outcomes. Children’s Mercy-Kansas City (CMKC) developed an NTM working group to facilitate implementation of standardized NTM management. Methods. NTM working group: Pulmonologist (CF Center Director), Infectious Diseases specialist, nurse practitioner (CF Center Coordinator), and pharmacist. Sought expertise from the Director of Microbiology Laboratory regarding susceptibility testing. Developed NTM Management Guide from guidelines and other available literature. Diagnosis and management algorithm. Medication resource table.


Infectious Disease | Pediatrics | Pharmacy and Pharmaceutical Sciences | Pulmonology


Presented at the Midwest Cystic Fibrosis Consortium; Iowa City, IA; April 27-28, 2018.

Implementation Of A Guideline-Based Nontuberculous Mycobacteria Management Algorithm



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.